LX9211, an Orally-Administered, Non-opioid, AAK1 Inhibitor for Painful Diabetic Peripheral Neuropathy-Results from a Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study-MedSci.cn

LX9211, an Orally-Administered, Non-opioid, AAK1 Inhibitor for Painful Diabetic Peripheral Neuropathy-Results from a Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study

Busui, R; Patel, A; Sang, CN; Granowitz, CB; Banks, PL; Pierce, P; Sun, FW; Gopinathan, S

DIABETES, 2023; 72 ():

科室
- - 订阅+
  - 更多科室
工具
服务